Studies showed that the polymorphismsin CD44 play a substantial role in the development ofbreast (29) and bladder cancers (30) in the northern Indianpopulation and they may be important as a molecularprognostic markers. This evidence concerns the gene CD44 and urinary bladder carcinoma.